Drug could slow motor neuron disease
A drug with the potential to delay the progression of motor neuron disease (MND) could be in human trials within three years.
University of Queensland researchers have shown the anti-inflammatory drug PMX205 is effective in animals with the disease, delaying the progression of symptoms and extending survival.
